To include your compound in the COVID-19 Resource Center, submit it here.

Follow-on roundup: Ascendis, Catalent

Ascendis Pharma A/S (NASDAQ:ASND) and Catalent Inc. (NYSE:CTLT) each priced follow-on offerings, raising more than $380 million.

Ascendis raised $134.9 million on Wednesday through the sale of 3.8 million ADSs

Read the full 299 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE